Based in Boston, MA, Xontogeny seeks to accelerate the development of life science technologies by providing entrepreneurs with the leadership, strategic guidance and operational support necessary to increase the probability of success in early drug and technology development. Through a differentiated approach, the Xontogeny team partners with the founding scientists and entrepreneurs of new ventures to support their vision while allowing a more efficient development model to benefit company founders and early equity holders.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/20/17 | $15,000,000 | Series A |
Perceptive Advisors | undisclosed |
